Page 32 - Eton Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eton pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eton Pharmaceuticals Today - Breaking & Trending Today

Eton Pharmaceuticals (NASDAQ:ETON) Downgraded by Zacks Investment Research to Strong Sell

Eton Pharmaceuticals (NASDAQ:ETON – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a report released on Thursday, Zacks.com reports. According to Zacks, “Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and […] ....

United States , Deer Park , Fifth Third Bancorp , Eton Pharmaceuticals , Eton Pharmaceuticals Inc , Zacks Investment Research , Eton Pharmaceuticals Get Rating , Highvista Strategies , Capital Partners , Jpmorgan Chase Co , Paradigm Capital Management Inc , Third Bancorp , Get Rating , Capital Management , Vista Strategies , Carglumic Acid , N Acetylglutamate Synthase , Nasdaq Eton ,

Analysts' Downgrades for June 2nd (AC, CCMP, CMCSA, CWBR, DINO, DIS, EFTR, EQT, ETN, ETON)

Analysts’ downgrades for Thursday, June 2nd: Associated Capital Group (NYSE:AC) was downgraded by analysts at StockNews.com from a hold rating to a sell rating. CMC Materials (NASDAQ:CCMP) was downgraded by analysts at StockNews.com from a buy rating to a hold rating. Comcast (NASDAQ:CMCSA) was downgraded by analysts at StockNews.com from a strong-buy rating to a […] ....

United States , Menlo Park , United Kingdom , Deer Park , New Mexico , City Of , Factset Research Systems , Effector Therapeutics Inc , Eton Pharmaceuticals , Seachange International , Eton Pharmaceuticals Inc , Hf Sinclair Corporation , Capital Group , Zacks Investment Research , Cohbar Inc , Getty Realty , Locust Walk Acquisition Corp , Hollyfrontier Corporation , Genel Energy , Set Research Systems , Kurdistan Region , Change International , Associated Capital Group Inc , Cmc Materials Inc , Comcast Co , Hf Sinclair Co ,

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) to Post Q2 2022 Earnings of ($0.21) Per Share, B. Riley Forecasts

Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Rating) – Investment analysts at B. Riley reduced their Q2 2022 EPS estimates for Eton Pharmaceuticals in a research report issued to clients and investors on Tuesday, May 31st. B. Riley analyst J. Walsh now anticipates that the company will post earnings per share of ($0.21) for the quarter, […] ....

Paradigm Capital Management Inc , Jpmorgan Chase Co , Eton Pharmaceuticals , Goldman Sachs Group Inc , Eton Pharmaceuticals Inc , Eton Pharmaceuticals Get Rating , Get Rating , Capital Management , Sachs Group , Street Corp , Carglumic Acid , N Acetylglutamate Synthase , Nasdaq Eton , Earnings Estimates , B Riley ,

Harrow Health (NASDAQ:HROW) Downgraded to "D+" at TheStreet

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock. ....

Eton Pharmaceuticals Inc , Zacks Investment Research , Harrow Health Company Profile Get Rating , Gradient Investments , Franklin Resources Inc , Harrow Health , Acadian Asset Management , Harrow Health Inc , Leeward Financial Partners , Pharmaceuticals Inc , Surface Ophthalmics Inc , Barclays Plc , Opaleye Management Inc , Get Rating , Opaleye Management , Asset Management , Health Company Profile , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals ,

Harrow Health (NASDAQ:HROW) PT Raised to $20.00

Harrow Health (NASDAQ:HROW – Get Rating) had its price target upped by equities researchers at B. Riley from $17.00 to $20.00 in a research report issued to clients and investors on Friday, The Fly reports. B. Riley’s target price would suggest a potential upside of 246.62% from the stock’s current price. Separately, Zacks Investment Research […] ....

Harrow Health Get Rating , Eton Pharmaceuticals Inc , Zacks Investment Research , Stansberry Asset Management , Wasatch Advisors Inc , Prelude Capital Management , Harrow Health , Harrow Health Inc , Pharmaceuticals Inc , Surface Ophthalmics Inc , Opaleye Management Inc , Get Rating , Opaleye Management , Street Group , Asset Management , Street Corp , Capital Management , Wasatch Advisors , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Nasdaq Hrow , Boost Price Target , B Riley ,